Predicting the survival of patients with breast carcinoma using tumor size

被引:156
作者
Michaelson, JS
Silverstein, M
Wyatt, J
Weber, G
Moore, R
Halpern, E
Kopans, DB
Hughes, K
机构
[1] Massachusetts Gen Hosp, Div Surg Oncol, Dept Pathol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA
[4] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA
[5] Univ So Calif, Harold E & Henrietta C Lee Breast Ctr, USC Norris Canc Ctr, Los Angeles, CA USA
[6] MIT, Dept Elect Engn, Cambridge, MA 02139 USA
[7] Harvard Univ, Dept Radiol, Sch Med, Boston, MA 02115 USA
关键词
breast carcinoma; tumor size; metastasis; survival; mammography;
D O I
10.1002/cncr.10742
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Tumor size has long been recognized as the strongest predictor of the outcome of patients with invasive breast carcinoma, although it has not been settled whether the correlation between tumor size and the chance of death is independent of the method of detection, nor is it clear how tumor size at the time of treatment may be translated into a specific expectation of survival. In this report, the authors provide such a method. METHODS. A Kaplan-Meier survival analysis was carried out for a population of 1352 women with invasive breast carcinoma who were treated at the Van Nuys Breast Center between 1966 and 1990, and the data were analyzed together with survival data published by others. RESULTS. The authors found that the survival of patients with invasive breast carcinoma was a direct function of tumor size, independent of the method of detection. The results showed that the correlation between tumor size and survival was well fit by a simple equation, with which survival predictions could be made from information on tumor size. For example, a comparison of three large populations studied over the last 5 decades revealed a marked improvement (approximate to35% absolute) in the survival of patients with invasive breast carcinoma diagnosed on clinical grounds that could be ascribed to a reduction in tumor size. However, the capacity of screening mammography to find smaller tumors remains the best way reduce breast carcinoma deaths, with the potential for adding an additional approximate to20% absolute reduction in breast carcinoma deaths. The mathematic correlation between tumor size and survival is consistent with a biologic mechanism in which lethal distant metastasis occurs by discrete events of spread such that, for every invasive breast carcinoma cell in the primary tumor at the time of surgery, there is approximately a 1-in-1-billion chance that a lethal distant metastasis has formed. CONCLUSIONS. The correlation between tumor size and lethality is well captured by a simple equation that is consistent with breast carcinoma death as the result of discrete events of cellular spread occurring with small but definable probabilities. (C) 2002 American Cancer Society.
引用
收藏
页码:713 / 723
页数:11
相关论文
共 47 条
[21]  
Kuukasjarvi T, 1997, CANCER RES, V57, P1597
[22]  
Michaelson J, 1999, ANTICANCER RES, V19, P4853
[23]   Breast cancer: Computer simulation method for estimating optimal intervals for screening [J].
Michaelson, JS ;
Halpern, E ;
Kopans, DB .
RADIOLOGY, 1999, 212 (02) :551-560
[24]  
*NIH, 2000, CONS DEV C STAT NOV
[25]  
NORTON L, 1988, CANCER RES, V48, P7067
[26]   UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years [J].
Peto, R ;
Boreham, J ;
Clarke, M ;
Davies, C ;
Beral, V .
LANCET, 2000, 355 (9217) :1822-1822
[27]  
Pluda JM, 1997, SEMIN ONCOL, V24, P203
[28]   NATURAL-HISTORY OF NODE-NEGATIVE BREAST-CANCER - A STUDY OF 826 PATIENTS WITH LONG-TERM FOLLOW-UP [J].
QUIET, CA ;
FERGUSON, DJ ;
WEICHSELBAUM, RR ;
HELLMAN, S .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1144-1151
[29]   Natural history of node-positive breast cancer: The curability of small cancers with a limited number of positive nodes [J].
Quiet, CA ;
Ferguson, DJ ;
Weichselbaum, RR ;
Hellman, S .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3105-3111
[30]  
ROCHE CA, 1999, DEV RISK ASSESSMENT